Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy

GLIA

Volumn 58, Issue 16, 2010, Pages 1996-2004

  Mishra, Anusha ^a   Newman, Eric A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Diabetes; GLIAL cells; INOS; Neurovascular coupling; Retina

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENZYME INHIBITION; GLIA CELL; HYPEREMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA BLOOD FLOW; UPREGULATION; VASODILATATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENZYME INHIBITORS; GUANIDINES; HYPEREMIA; MALE; NEUROGLIA; NITRIC OXIDE SYNTHASE TYPE II; PHOTIC STIMULATION; RATS; RATS, LONG-EVANS; RETINA; RETINAL VESSELS; VASODILATION;

EID: 78649432851     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21068     Document Type: Article

References (40)

1. Alder VA, Su EN, Yu DY, Cringle SJ, Yu PK. 1997. Diabetic retinopathy: Early functional changes. Clin Exp Pharmacol Physiol 24:785-788.
2. Amruthesh SC, Falck JR, Ellis EF. 1992. Brain synthesis and cerebro vascular action of epoxygenase metabolites of arachidonic acid. J Neurochem 58:503-510.
3. Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, Kester M, Kimball SR, Krady JK, LaNoue KF, Norbury CC, Quinn PG, Sandirasegarane L, Simpson IA. 2006. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55:2401-2411.
4. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. 1998. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102:783-791.
5. Blanco VM, Stern JE, Filosa JA. 2008. Tone-dependent vascular responses to astrocyte-derived signals. Am J Physiol Heart Circ Physiol 294:H2855-H2863.
6. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. 1986. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232:1629-1632.
7. Cattell V, Jansen A. 1995. Inducible nitric oxide synthase in inflammation. Histochem J 27:777-784.
8. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR Jr, Williamson JR, McDaniel ML. 1992. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41:552-556.
9. Du Y, Sarthy VP, Kern TS. 2004. Interaction between NO, COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. Am J Physiol Regul Integr Comp Physiol 287:R735-R741.
10. Du Y, Smith MA, Miller CM, Kern TS. 2002. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem 80:771-779.
11. Ellis EF, Wei EP, Kontos HA. 1979. Vasodilation of cat cerebral arterioles by prostaglandins D2, E2, G2, and I2 Am J Physiol 237:H381-H385.
12. Feit-Leichman RA, Kinouchi R, Takeda M, Fan Z, Mohr S, Kern TS, Chen DF. 2005. Vascular damage in a mouse model of diabetic retinopathy: Relation to neuronal and glial changes. Invest Ophthalmol Vis Sci 46:4281-4287.
13. Filosa JA, Bonev AD, Nelson MT. 2004. Calcium dynamics in cortical astrocytes and arterioles during neurovascular coupling. Circ Res 95:e73-e81.
14. Garhofer G, Zawinka C, Resch H, Kothy P, Schmetterer L, Dorner GT. 2004. Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol 88:887-891.
15. Gariano RF, Gardner TW. 2005. Retinal angiogenesis in development and disease. Nature 438:960-966.
16. Gordon GRJ, Choi HB, Rungta RL, Ellis-Davies GCR, MacVicar BA. 2008. Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature 456:745-749.
17. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M. 1991. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 88:11555-11558.
18. Harder DR, Gebremedhin D, Narayanan J, Jefcoat C, Falck JR, Campbell WB, Roman R. 1994. Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am J Physiol 266:H2098-H2107.
19. Ignarro LJ. 2002. Nitric oxide as a unique signaling molecule in the vascular system: A historical overview. J Physiol Pharmacol 53:t-14.
20. Kessler P, Popp R, Busse R, Schini-Kerth VB. 1999. Proinflammatory mediators chronically downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism. Circulation 99:1878-1884.
21. Kirwin SJ, Kanaly ST, Linke NA, Edelman JL. 2009. Strain-dependent increases in retinal inflammatory proteins and photoreceptor FGF-2 expression in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 50:5396-5404.
22. Koehler RC, Roman RJ, Harder DR. 2009. Astrocytes and the regulation of cerebral blood flow. Trends Neurosci 32:160-169.
23. Kowluru RA, Engerman RL, Kern TS. 2000. Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine. Curr Eye Res 21:814-819.
24. Li Q, Puro DG. 2002. Diabetes-induced dysfunction of the glutamate transporter in retinal MCuller cells. Invest Ophthalmol Vis Sci 43:3109-3116.
25. Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D, Strother JM. 1998. Glial reactivity and impaired glutamate metabolism in shortterm experimental diabetic retinopathy. Diabetes 47:815-820.
26. Mandecka A, Dawczynski J, Blum M, Muller N, Kloos C, Wolf G, Vilser W, Hoyer H, Muller UA. 2007. Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 30:3048-3052.
27. Metea MR, Newman EA. 2006. Glial cells dilate and constrict blood vessels: A mechanism of neurovascular coupling. J Neurosci 26:2862-2870.
28. Mishra A, Srienc AI, Clark BD, Newman EA. 2010. Oxygen modulates functional hyperemia in the retina. Soc Neurosci Abstr (in press).
29. Mizutani M, Gerhardinger C, Lorenzi M. 1998. MCuller cell changes in human diabetic retinopathy. Diabetes 47:445-449.
30. Mizutani M, Kern TS, Lorenzi M. 1996. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97:2883-2890.
31. Mulligan SJ, MacVicar BA. 2004. Calcium transients in astrocyte end feet cause cerebrovascular constrictions. Nature 431:195-199.
32. Newman EA. 2001. Propagation of intercellular calcium waves in retinal astrocytes and MCuller cells. J Neurosci 21:2215-2223.
33. Porter JT, McCarthy KD. 1996. Hippocampal astrocytes in situ respond to glutamate released from synaptic terminals. J Neurosci 16:5073- 5081.
34. Riva CE, Logean E, Falsini B. 2005. Visually evoked hemodynamical response and assessment of neurovascular coupling in the optic nerve and retina. Prog Ret Eye Res 24:183-215.
35. Roman RJ. 2002. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82:131-185.
36. Rungger-Brandle E, Dosso AA. 2003. Streptozotocin-induced diabetes-A rat model to study involvement of retinal cell types in the onset of diabetic retinopathy. Adv Exp Med Biol 533:197-203.
37. Takano T, Tian GF, Peng W, Lou N, Libionka W, Han X, Nedergaard M. 2006. Astrocyte-mediated control of cerebral blood flow. Nat Neurosci 9:260-267.
38. van Dijk HW, Kok PH, Garvin M, Sonka M, Devries JH, Michels RP, van Velthoven ME, Schlingemann RO, Verbraak FD, Abramoff MD. 2009. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci 50:3404-3409.
39. Yu DY, Cringle SJ, Su EN, Yu PK, Jerums G, Cooper ME. 2001. Pathogenesis and intervention strategies in diabetic retinopathy. Clin Experiment Ophthalmol 29:164-166.
40. Zonta M, Angulo MC, Gobbo S, Rosengarten B, Hossmann KA, Pozzan T, Carmignoto G. 2003. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 6:43- 50.